Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Dengue”

79 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 79 results

Large-scale testing (Phase 3)Study completedNCT06744777
What this trial is testing

The Comparative Efficacy of Standard Treatment Plus Ribavirin vs Standard Treatment Alone in Preventing Clinically Significant Hemorrhage in Patients With Dengue Fever

Who this might be right for
Dengue FeverDengue Hemorrhagic FeverSevere Dengue
Khyber Medical University Peshawar 284
Early research (Phase 1)Study completedNCT00094705
What this trial is testing

Safety of and Immune Response to a Dengue Virus Vaccine (rDEN2/4delta30[ME]) in Healthy Adults

Who this might be right for
Dengue Fever
National Institute of Allergy and Infectious Diseases (NIAID) 28
Not applicableStudy completedNCT05938647
What this trial is testing

Severe Dengue in Critical Care at Villavicencio, Colombia.

Who this might be right for
Severe Dengue
Hospital Departamental de Villavicencio 199
Testing effectiveness (Phase 2)Study completedNCT03432442
What this trial is testing

Pharmacokinetics and Pharmacodynamics of Ivermectin in Pediatric Dengue Patients

Who this might be right for
Dengue Hemorrhagic Fever
Mahidol University 24
Testing effectiveness (Phase 2)Study completedNCT01064141
What this trial is testing

Dengue Vaccine in Healthy Toddlers Aged 12 to 15 Months in the Philippines

Who this might be right for
Dengue FeverDengue Hemorrhagic Fever
Sanofi 210
Not applicableUnknownNCT04672577
What this trial is testing

Infection Tracking in Travellers. The Project Aims to Identify Profiles of Travel-associated Illness and to Follow up on Long-term Sequelae of Arboviral Infections and Malaria

Who this might be right for
Travel-Related IllnessMalariaDengue+6 more
Patricia Schlagenhauf 10,000
Not applicableLooking for participantsNCT07409857
What this trial is testing

International Registry of Dengue Infection in Congenital Bleeding Disorders (DengueCBDR)

Who this might be right for
Dengue DiseaseDengue Haemorrhagic FeverDengue Fever+1 more
Mahidol University 100
Testing effectiveness (Phase 2)Study completedNCT01488890
What this trial is testing

Immune Response to Different Schedules of a Tetravalent Dengue Vaccine Given With or Without Yellow Fever Vaccine

Who this might be right for
DengueDengue FeverDengue Hemorrhagic Fever+1 more
Sanofi Pasteur, a Sanofi Company 390
Not applicableStudy completedNCT07621848
What this trial is testing

Abdominal Sonographic Findings and Their Association With Thrombocytopenia in Dengue Fever: A Cross-Sectional Study From an Endemic Region

Who this might be right for
Dengue Fever
National Center for Gastroentestinal and Liver Disease 150
Testing effectiveness (Phase 2)Study completedNCT02628444
What this trial is testing

Immunogenicity and Safety of Different Vaccination Schedules of Tetravalent Dengue Vaccine in Healthy Subjects 9 to 50 Years of Age

Who this might be right for
Dengue FeverDengue Hemorrhagic Fever
Sanofi Pasteur, a Sanofi Company 1,050
Early research (Phase 1)Study completedNCT00375726
What this trial is testing

Safety of and Immune Response to a Dengue Virus Vaccine (rDEN3/4delta30[ME]) in Healthy Adults

Who this might be right for
Dengue
National Institute of Allergy and Infectious Diseases (NIAID) 58
Not applicableStudy completedNCT01477671
What this trial is testing

Prospective Dengue Seroprevalence Study in 5 to 10 Year-old Children

Who this might be right for
DengueDengue FeverDengue Hemorrhagic Fever
Sanofi Pasteur, a Sanofi Company 667
Large-scale testing (Phase 3)UnknownNCT00966628
What this trial is testing

Effect of Hypertonic Sodium Lactate on sVCAM-1 Level as Surrogate Marker of Endothelial Capillary Leakage in Pediatric Dengue Shock Syndrome Patients (DSS)

Who this might be right for
Dengue Shock Syndrome
Innogene Kalbiotech Pte. Ltd 50
Early research (Phase 1)Study completedNCT00831012
What this trial is testing

Safety of and Immune Response to a Dengue Virus Vaccine (rDEN3delta30/31-7164) in Healthy Adults

Who this might be right for
Dengue Fever
National Institute of Allergy and Infectious Diseases (NIAID) 56
Testing effectiveness (Phase 2)Study completedNCT01601613
What this trial is testing

Activated Recombinant Human Factor VII in Patients With Dengue Haemorrhagic Fever

Who this might be right for
Acquired Bleeding DisorderDengue Haemorrhagic Fever
Novo Nordisk A/S 28
Early research (Phase 1)Study completedNCT01072786
What this trial is testing

Evaluation of the Safety and Immune Response of Five Admixtures of a Tetravalent Dengue Virus Vaccine

Who this might be right for
Dengue
National Institute of Allergy and Infectious Diseases (NIAID) 141
Not applicableStudy completedNCT04048837
What this trial is testing

Prospective Study for the Evaluation of Dengue Prognostic Biomarkers in Singapore

Who this might be right for
Dengue Hemorrhagic FeverDengue Shock SyndromeSevere Dengue
National University Hospital, Singapore 200
Testing effectiveness (Phase 2)Study completedNCT00875524
What this trial is testing

Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy Subjects

Who this might be right for
Dengue VirusDengue FeverDengue Hemorrhagic Fever+1 more
Sanofi Pasteur, a Sanofi Company 180
Not applicableLooking for participantsNCT07000747
What this trial is testing

Molecular and Cellular Basis of Severe Forms of Dengue in Sickle Cell Patients

Who this might be right for
Dengue (Virus); Fever, SandflySickle Cell Disease
Centre Hospitalier Universitaire de la Guadeloupe 130
Testing effectiveness (Phase 2)Study completedNCT00468858
What this trial is testing

Two Doses of WRAIR Dengue Vaccine Administered Six Months Apart to Healthy Adults and Children

Who this might be right for
Dengue FeverDengue Hemorrhagic FeverDengue Shock Syndrome
U.S. Army Medical Research and Development Command 636
Next Page